Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo

ClinicalTrials.gov ID: NCT06109649

Public ClinicalTrials.gov record NCT06109649. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 2:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Arm, Open Label, Phase III Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet B (NB-UVB) Light Versus NB-UVB Light Alone in the Treatment of Vitiligo

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The CUV105 study will assess the efficacy and safety of afamelanotide and NB-UVB light in patients with vitiligo on the body and face versus NB-UVB light alone.

Study identification

NCT ID
NCT06109649
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Clinuvel, Inc.
Industry
Enrollment
200 participants

Conditions and interventions

Conditions

Interventions

Drug · Procedure

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 11, 2023 (Actual)
Primary completion
Dec 2025 (Estimated)
Completion
Jun 2026 (Estimated)
Last update posted
Jul 8, 2025

2023 – 2026

United States locations

U.S. sites
25
U.S. states
17
U.S. cities
25
Facility City State ZIP Site status
CLINUVEL site Birmingham Alabama 00000 —
CLINUVEL site Fresno California 00000 —
CLINUVEL site Los Angeles California 00000 —
CLINUVEL site Palo Alto California 00000 —
CLINUVEL site San Diego California 00000 —
CLINUVEL Site Washington D.C. District of Columbia 00000 —
CLINUVEL site Miami Florida 00000 —
CLINUVEL site Miramar Florida 00000 —
CLINUVEL site Alpharetta Georgia 00000 —
CLINUVEL site Augusta Georgia 00000 —
CLINUVEL site Chicago Illinois 00000 —
CLINUVEL site Baton Rouge Louisiana 00000 —
CLINUVEL site Detroit Michigan 00000 —
CLINUVEL site Minneapolis Minnesota 00000 —
CLINUVEL site Roseville Minnesota 00000 —
CLINUVEL Site Lee's Summit Missouri 00000 —
CLINUVEL site Rochester New York 00000 —
CLINUVEL site Cleveland Ohio 00000 —
CLINUVEL site Philadelphia Pennsylvania 00000 —
CLINUVEL Site Charleston South Carolina 00000 —
CLINUVEL site Thompson's Station Tennessee 00000 —
CLINUVEL Site Cedar Park Texas 00000 —
CLINUVEL site Dallas Texas 00000 —
CLINUVEL site Tyler Texas 00000 —
CLINUVEL site Charlottesville Virginia 00000 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06109649, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 8, 2025 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06109649 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →